Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
7.35
+0.13 (1.80%)
At close: Dec 5, 2025, 4:00 PM EST
7.30
-0.05 (-0.68%)
After-hours: Dec 5, 2025, 7:58 PM EST
Tilray Brands Revenue
Tilray Brands had revenue of $209.50M in the quarter ending August 31, 2025, with 4.73% growth. This brings the company's revenue in the last twelve months to $830.77M, up 2.31% year-over-year. In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M with 4.10% growth.
Revenue (ttm)
$830.77M
Revenue Growth
+2.31%
P/S Ratio
0.83
Revenue / Employee
$292,317
Employees
2,842
Market Cap
829.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 821.31M | 32.37M | 4.10% |
| May 31, 2024 | 788.94M | 161.82M | 25.80% |
| May 31, 2023 | 627.12M | -1.25M | -0.20% |
| May 31, 2022 | 628.37M | 115.29M | 22.47% |
| May 31, 2021 | 513.09M | 107.76M | 26.59% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TLRY News
- 7 hours ago - This Stock-Split Stock Is Up 90% in the Past 6 Months: Is There More Upside Ahead? - The Motley Fool
- 20 hours ago - Why Tilray Stock Dived by 10% This Week - The Motley Fool
- 2 days ago - Is There a Future for Tilray Brands? - The Motley Fool
- 2 days ago - Down 66% From Its High, Can Tilray Brands Stock Turn Things Around? - The Motley Fool
- 2 days ago - Tilray Releases the Ultimate 2025 Holiday Drink Gift Guide, Celebrating Seasonal Sips and Moments of Connection from Coast to Coast - GlobeNewsWire
- 4 days ago - Canadian Cannabis Market Outlook for December 2025: Key Trends for Investors - MarijuanaStocks
- 5 days ago - What a Hemp Crackdown in the U.S. Could Mean for Tilray's Growth Opportunities - The Motley Fool
- 7 days ago - Tilray Plunges Ahead of a 1-for-10 Reverse Stock Split. Here's What You Need to Know - Investopedia